Yasser F. Hassan, Eman Alzahrani, Roshdy E. Saraya, Mohamed A. Abdel-Lateef, Ehab A. M. El-Shoura, Hany A. Batakoushy, Adel Ehab Ibrahim, Abd-ElAziem Farouk, Mohamed A. A. Abdel-Aal, Baher I. Salman
{"title":"一种有前途的绿色荧光法分析人体血浆中的依多沙班,使用绿色碳点装饰铽离子","authors":"Yasser F. Hassan, Eman Alzahrani, Roshdy E. Saraya, Mohamed A. Abdel-Lateef, Ehab A. M. El-Shoura, Hany A. Batakoushy, Adel Ehab Ibrahim, Abd-ElAziem Farouk, Mohamed A. A. Abdel-Aal, Baher I. Salman","doi":"10.1007/s11696-024-03796-6","DOIUrl":null,"url":null,"abstract":"<div><p>An innovative green synthesized carbon quantum dot was decorated with terbium as new fluorescent nanoprobes (Tb,N@CQDs) and developed as eco-friendliness, water-soluble, cost-effectiveness, and biocompatibility quantum dots for analysis of edoxaban (EDN). A microwave synthesis technique produced environmentally friendly (Tb,N@CQDs) in just 7 min, boasting a high quantum yield of 35.44%. The green synthesized quantum dots were then utilized in the development of a sensor for detecting trace amounts of edoxaban (EDN). EDN is a newly approved anticoagulant medication by the US-FDA for treating deep vein thrombosis (DVT) in patients initially treated with a parenteral anticoagulant for 5–10 days. The introduction of EDN resulted in a gradual decrease in the fluorescence intensity of Tb,N@CQDs at 436 nm within the calibration range 30.0 – 350.0 ng mL<sup>−1</sup>. The creative method was validated for bio-analytical applications by FDA standards with a lower limit of quantitation (LOQ) 18.33 ng mL<sup>−1</sup>, demonstrating simplicity, affordability, high sensitivity, and exceptional selectivity, making it suitable for clinical research. This established method proved effective in quantifying EDN in human plasma with percent of recovery (98.88 ± 2.74), pharmaceutical formulations, and pharmacokinetic studies, showcasing sustainability by incorporating recent evaluation criteria.</p></div>","PeriodicalId":513,"journal":{"name":"Chemical Papers","volume":"79 1","pages":"497 - 510"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A promising green fluorimetric approach for analysis of edoxaban in real human plasma using green carbon dots decorated with terbium ions\",\"authors\":\"Yasser F. Hassan, Eman Alzahrani, Roshdy E. Saraya, Mohamed A. Abdel-Lateef, Ehab A. M. El-Shoura, Hany A. Batakoushy, Adel Ehab Ibrahim, Abd-ElAziem Farouk, Mohamed A. A. Abdel-Aal, Baher I. Salman\",\"doi\":\"10.1007/s11696-024-03796-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>An innovative green synthesized carbon quantum dot was decorated with terbium as new fluorescent nanoprobes (Tb,N@CQDs) and developed as eco-friendliness, water-soluble, cost-effectiveness, and biocompatibility quantum dots for analysis of edoxaban (EDN). A microwave synthesis technique produced environmentally friendly (Tb,N@CQDs) in just 7 min, boasting a high quantum yield of 35.44%. The green synthesized quantum dots were then utilized in the development of a sensor for detecting trace amounts of edoxaban (EDN). EDN is a newly approved anticoagulant medication by the US-FDA for treating deep vein thrombosis (DVT) in patients initially treated with a parenteral anticoagulant for 5–10 days. The introduction of EDN resulted in a gradual decrease in the fluorescence intensity of Tb,N@CQDs at 436 nm within the calibration range 30.0 – 350.0 ng mL<sup>−1</sup>. The creative method was validated for bio-analytical applications by FDA standards with a lower limit of quantitation (LOQ) 18.33 ng mL<sup>−1</sup>, demonstrating simplicity, affordability, high sensitivity, and exceptional selectivity, making it suitable for clinical research. This established method proved effective in quantifying EDN in human plasma with percent of recovery (98.88 ± 2.74), pharmaceutical formulations, and pharmacokinetic studies, showcasing sustainability by incorporating recent evaluation criteria.</p></div>\",\"PeriodicalId\":513,\"journal\":{\"name\":\"Chemical Papers\",\"volume\":\"79 1\",\"pages\":\"497 - 510\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-11-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemical Papers\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s11696-024-03796-6\",\"RegionNum\":4,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Engineering\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Papers","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1007/s11696-024-03796-6","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0
摘要
以铽作为新型荧光纳米探针(Tb,N@CQDs)修饰绿色合成碳量子点,并将其作为生态友好、水溶性、成本效益和生物相容性好的量子点用于分析依多沙班(EDN)。采用微波合成技术,仅需7分钟即可生产出环境友好的(Tb,N@CQDs),量子产率高达35.44%。绿色合成量子点随后被用于检测痕量伊多沙班(EDN)的传感器的开发。EDN是美国fda新批准的一种抗凝药物,用于治疗最初接受肠外抗凝治疗5-10天的深静脉血栓(DVT)患者。EDN的引入导致Tb,N@CQDs在436 nm处的荧光强度逐渐降低,校准范围为30.0 - 350.0 ng mL−1。该方法通过FDA标准验证,定量下限(LOQ)为18.33 ng mL−1,具有简便、经济、高灵敏度和卓越的选择性,适用于临床研究。结果表明,该方法可有效定量测定人血浆中EDN,回收率(98.88±2.74),适用于药物配方和药代动力学研究,并结合最新评价标准,具有可持续性。
A promising green fluorimetric approach for analysis of edoxaban in real human plasma using green carbon dots decorated with terbium ions
An innovative green synthesized carbon quantum dot was decorated with terbium as new fluorescent nanoprobes (Tb,N@CQDs) and developed as eco-friendliness, water-soluble, cost-effectiveness, and biocompatibility quantum dots for analysis of edoxaban (EDN). A microwave synthesis technique produced environmentally friendly (Tb,N@CQDs) in just 7 min, boasting a high quantum yield of 35.44%. The green synthesized quantum dots were then utilized in the development of a sensor for detecting trace amounts of edoxaban (EDN). EDN is a newly approved anticoagulant medication by the US-FDA for treating deep vein thrombosis (DVT) in patients initially treated with a parenteral anticoagulant for 5–10 days. The introduction of EDN resulted in a gradual decrease in the fluorescence intensity of Tb,N@CQDs at 436 nm within the calibration range 30.0 – 350.0 ng mL−1. The creative method was validated for bio-analytical applications by FDA standards with a lower limit of quantitation (LOQ) 18.33 ng mL−1, demonstrating simplicity, affordability, high sensitivity, and exceptional selectivity, making it suitable for clinical research. This established method proved effective in quantifying EDN in human plasma with percent of recovery (98.88 ± 2.74), pharmaceutical formulations, and pharmacokinetic studies, showcasing sustainability by incorporating recent evaluation criteria.
Chemical PapersChemical Engineering-General Chemical Engineering
CiteScore
3.30
自引率
4.50%
发文量
590
期刊介绍:
Chemical Papers is a peer-reviewed, international journal devoted to basic and applied chemical research. It has a broad scope covering the chemical sciences, but favors interdisciplinary research and studies that bring chemistry together with other disciplines.